| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0246 | 4-acpam | Selectiveγ |
|
| DCC0247 | 4-acpca | Selectiveγ |
|
| DCC0248 | 4-acpha | Selectiveγ‑Aminobutyric Acid(C) (GABAC) Antagonist |
|
| DCC0249 | 4alpha,5alpha-oxidoeudesm-11-en-3-one | Natural selective estrogen receptor modulator, showing higher binding affinity to ER-β than ER-α with both estrogenic and antiestrogenic effects depending on the E2 concentration |
|
| DCC0250 | 4-azido-l-phenylalanine Hydrochloride | Mutually Orthogonal Bioorthogonal Amino Acid, Enabling Efficient Protein Dual-Labeling in Cells |
|
| DCC0251 | 4-azido-n-ethyl-1,8-naphthalimide | Clickable fluorescent probe, enabling dynamic imaging of cell surface and intracellular fucosylation of glycoproteins and glycolipids. |
|
| DCC0252 | 4-benzoyl-l-phenylalanine | Photoreactive L-phenylalanine derivative, being as a photo cross-linking probe to incorporate into proteins, including ion channels, transporters and GPCRs |
|
| DCC0253 | 4-bromo-a23187 | Ca ionophore. potentiating responses to NMDA, but not quisqualate |
|
| DCC0254 | 4'-carboxybenzo-18c6 | Novel Transthyretin (TTR) Amyloidogenesis Inhibitor, stabilizing the TTR tetramer by binding to the allosteric sites on the molecular surface of the TTR tetramer |
|
| DCC0255 | 4-chlorokynurenine | Prodrug of 7-Cl-kynurenic acid (7-Cl-KYNA), a potent, selective antagonist of the NMDA/glycine receptor |
|
| DCC0256 | 4-cl-imt | Novel selective ligand of the Transport Inhibitor Resistant 1 (TIR1) |
|
| DCC0257 | 4-cyclopentene-1,3-dione | Potent Antifungal Inhibitor of Chitin Synthesis |
|
| DCC0258 | 4'-dma-7,8-dhf | Potent agonist of tropomyosin-receptor-kinase B (TrkB) receptor, possessing robust anti-apoptotic activity, promoting neurogenesis, and exhibiting potent antidepressant effect |
|
| DCC0259 | 4-fluoroamphetamine Hydrochloride | Dopamine reuptake inhibitor |
|
| DCC0260 | 4-me-pdtic | Novel Potent and Selective Kappa Opioid Receptor Antagonist |
|
| DCC0261 | 4-ome-arm1 | Novel ligand for LTA4H, dose responsively reducing LTB4 production in human neutrophils |
|
| DCC0262 | 4'-o-methylgrynullarin | Novel anti-austerity agent, inducing PANC-1 human pancreatic cancer cell death under nutrition starvation via inhibition of Akt/mTOR pathway |
|
| DCC0263 | 4'-o-methylresveratrol | Inhibitor of Androgen_receptor>androgen receptor (AR) transcriptional activity, more effective than resveratrol in inhibiting AKT>Akt phosphorylation |
|
| DCC0264 | 4-pridin-4-yl-2h-pyrazol-3-ylamine | Useful pharmaceutical building block |
|
| DCC0265 | 4-quinolin-4-yl-2h-pyrazol-3-ylamine | Useful pharmaceutical building block |
|
| DCC0266 | 4-quinolineacetonitrile | Bulding Block |
|
| DCC0267 | 5,6-eet | Inhibitor of T-type voltage-gated calcium channels (Cav3), inhibiting isoforms Cav3.1, Cav3.2, and Cav3.3, decreasing nifedipine-resistant phenylephrine-induced vasoconstriction via Cav3.2 blockade |
|
| DCC0268 | 5172-mcp1p3 | Novel inhibitor of HCV NS3-NS4A Serine Proteinase |
|
| DCC0269 | 5-actmf | Novel Inducer of G2/M arrest, Apoptosis and Autophagy in Cancer Cells |
|
| DCC0270 | 5-alpha-hydroxy-laxogenin Featured | 5-alpha-hydroxy-laxogenin is a derivative of the spirostane-type steroid, laxogenin. 5α-Hydroxy-laxogenin can be used as a plant-based anabolic agent as a dietary supplement. |
|
| DCC0271 | 5'-amino-5'-deoxyadenosine | Adenosine kinase inhibitor |
|
| DCC0272 | 5'-brluc | Brominated luciferin, being more cell permeant than luciferin |
|
| DCC0273 | 5-bromo-ds2 | Novel potent δ-selective allosteric modulator, Ki(α4β1δ) 0.06 µM |
|
| DCC0274 | 5-chloro-ds2 | Novel potent δ-selective allosteric modulator, Ki(α4β1δ) 0.14 µM |
|
| DCC0275 | 5-citep | Novel HIV-1 integrase inhibitor |
|
